Successful treatment of imported cerebral malaria with artesunate-mefloquine combination therapy

Journal of the Formosan Medical Association

Volumn 105, Issue 1, 2006, Pages 86-89

  Sun, Hsin Yun ^a   Fang, Chi Tai ^a   Wang, Jann Tay ^a   Kuo, Ping Hung ^a   Chen, Yee Chun ^a   Chang, Shan Chwen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Artesunate; Cerebral malaria; Combination Therapy; Mefloquine

Indexed keywords

ARTESUNATE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; MEFLOQUINE; NITROGEN; PRIMAQUINE; QUININE; UREA;

ADULT; ANAMNESIS; ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN MALARIA; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOPENIA; DRUG SUBSTITUTION; ENCEPHALITIS; ERADICATION THERAPY; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITEMIA; RETICULOSIS; THROMBOCYTE COUNT; TRAVEL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 31144455421     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60114-5     Document Type: Article

References (17)

1. Taiwan Malaria Research Institute and WHO Malaria Team. Malaria control and eradication in Taiwan: progress report, May 1952 to June 1957. Bull World Health Organ 1958;19: 595-620.
2. Farid MA, Pinto N, Chow CY. Assignment report of the WHO evaluation team for the certification of achieved malaria eradication in Taiwan. (9 November-18 December 1964). China: WHO, 7-E (WP) M2/72/2, 1966:1-130.
3. Fang CT, Chang HL, Hsieh WC. Malaria eradication on islands. Lancet 2001;357:560.
4. Department of Health, Executive Yuan, Republic of China. Health and Vital Statistics. 1. General Health Statistics 1997. Taipei: Department of Health, Executive Yuan, Republic of China, 1997:348.
5. Fang CT, Chang SC, Chang HL, et al. Imported malaria: successful treatment of 31 patients in the era of chloroquine resistance. J Formos Med Assoc 1999;98:683-7.
6. Anonymous. Drug resistance in malaria. In: Bruce-Chwatt LJ, ed. Chemotherapy of Malaria, revised 2nd edition. World Health Organization Monograph Series No. 27. Geneva: WHO, 1986:102-17.
7. Trape JF, Pison G, Preziosi MP, et al. Impact of chloroquine resistance on malaria mortality. C R Acad Sci Ill 1998;321: 689-97.
8. World Health Organization. Antimalarial Drug Combination Therapy: Report of WHO Technical Consultation, 4-5 April 2001. Geneva: World Health Organization (WHO/CDS/RBM/2001.35)
9. van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci 1999;20: 199-205.
10. Newton CR, Warrell DA. Neurological manifestations of falciparum malaria. Ann Neurol 1998;43:695-702.
11. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94:S1-90.
12. World Health Organization. Facts on ACTs (Artemisinin-based Combination Therapies). Geneva: World Health Organization. Available online: http://rbm.who.int/cmc_upload/0/000/015/364/RBMInfosheet_9.htm
13. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 1992; 339:821-4.
14. Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis 1994; 170:971-7.
15. Ribeiro IR, Olliaro P. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop (Mars) 1998;58:50-3.
16. Miller LG, Panosian CB. Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med 1997;336:1328.
17. Price R, van Vugt M, Phaipun L, et a. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 1999;60: 547-55.